[Summary] Products for the diagnosis and treatment of allergic diseases
Zhejiang WOLWO Bio-Pharmaceutical Co., Ltd. is a high-tech biopharmaceutical enterprise, listed on the Shenzhen Stock Exchange in January 2014 with stock code 300357, and has 7 subsidiaries under its umbrella. WOLWO only develops innovative drugs with significant technological or market advantages (including traditional Chinese medicines or natural medicines with confirmed efficacy, stem cell drugs), products with similar pharmaceutical functions, or new medical devices, and independently researches, invests in, or acquires technologies, products, or enterprises that meet the above standards. Possessing exclusive market status protected by patents (including but not limited to), this constitutes the company's fundamental product development strategy. The company is committed to the research, development, production, and sales of products for the diagnosis and treatment of allergic diseases, and is currently the only enterprise in China capable of providing sublingual immunotherapy drugs and the largest manufacturer of immunotherapy drugs and allergen detection reagents in Asia. The development of this product series not only provides allergy patients with safe and effective sublingual desensitization treatment, but also fills the gap in the production of standardized sublingual immunotherapy drugs and allergen skin prick test diagnostic reagents in China, and has established a professional academic marketing team mainly based on the "academic promotion" model for product promotion and sales.
In addition, WOLWO Bio-Pharmaceutical has established a wholly-owned subsidiary, Shanghai WOLWO Stem Cell Technology Co., Ltd., dedicated to the comprehensive research, development, and promotion of stem cell products. Leveraging the background of WOLWO Bio-Pharmaceutical as an innovative drug enterprise, it aims to develop innovative stem cell drugs with disease treatment and tissue repair functions through independent research and cooperation with domestic and international stem cell technology experts, to treat degenerative diseases related to aging, immune disorder-related diseases, and repair damaged tissues (e.g., spinal cord injury repair and bone regeneration), and ultimately achieve the manufacturing of artificial organs in vitro, thereby significantly extending human healthy lifespan.
The company adheres to the purpose of "curing diseases to save lives, and serving the country through industry", and aspires to become an important member of the international pharmaceutical industry. We sincerely invite you to join us and share in our success!
Company address: No. 636 Zhiyuan North Road, Wukang Town, Deqing County, Zhejiang Province (GMP production base and partial R&D centers)
Shanghai company address: 5th Floor, Building 40, No. 333 Qinjiang Road, Xuhui District, Shanghai (Management center: financial center, marketing center, administrative HR center, and partial R&D centers)
What does Zhejiang WOLWO Bio-Pharmaceutical Co., Ltd. require? Who is WOLWO Bio-Pharmaceutical hiring? WOLWO Bio-Pharmaceutical recruitment: 销售类占比最多占77%，其次是医疗卫生/美容保健类占24.5%. What education can get in at WOLWO Bio-Pharmaceutical? 大专占比最多占69.8%，其次是本科占22.7%. High education required at WOLWO Bio-Pharmaceutical? 硕士占4.7%，博士占0.5%. Work experience required at WOLWO Bio-Pharmaceutical? 不限占比最多占91.9%，其次是1-3年占5.4%. Where are the job locations at WOLWO Bio-Pharmaceutical? 湖州占比最多占5.9%，其次是上海占5.5%. Based on job postings from the past year, for reference only.
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
